Novartis' FCA Suit Discovery Request Slammed By States

By Khadijah M. Britton · September 30, 2014, 5:57 PM EDT

California, New York, New Jersey and eight other states on Monday challenged Novartis Pharmaceutical Corp.'s bid for information on their medication adherence programs, saying the information is irrelevant to a whistleblower...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

United States of America, ex rel, et al v. Novartis Pharmaceuticals Corporation

Case Number

Court

New York Southern

Nature of Suit

Other Statutes: False Claims Act

Date Filed

November 14, 2011

Recent Articles By Khadijah

July 17, 2015
Blue Cross Sues Mich. Hospital In Tribal Insurance Row
July 14, 2015
Religious Rights Group Enters VA Sweat Lodge Fray
June 25, 2015
Life Insurers Tell DC Circ. Exchange Fees Breach ACA
December 22, 2014
Oracle Gets 2nd Chance To Argue Oregon Waived Immunity
November 19, 2014
Contractor Lacks Standing For CMS Audit Suit, Fed. Circ. Told
October 24, 2014
GAO Denies Protest Over $559M Lockheed CMS Contract
October 16, 2014
Atty Deserves Sanctions For Baseless FCA Claims, Judge Says
October 10, 2014
Russia Investigates Ronald McDonald House For Tax Fraud
October 09, 2014
Whistleblower Seeks Stark Law Win In Hospital Kickback Suit
October 01, 2014
7th Circ. Rightly Nixed $9M FCA Verdict, Nursing Home Says